Stefan Vitorovic resigns from Praxis board; Chodakewitz and DeSimone fill committee roles

Praxis Precision Medicines, Inc.

Stefan Vitorovic resigned from the board effective August 12, 2022; no dispute or disagreement cited.
Jeffrey Chodakewitz appointed chair of Nominating and Corporate Governance Committee, replacing Vitorovic.
Jill DeSimone appointed to Audit Committee, replacing Vitorovic.
Vitorovic had served on the board since 2018.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stefan Vitorovic

Director

PRAX · Praxis Precision Medicines, Inc.

Effective: 2022-08-12
Filed: August 12, 2022, 7:59 PM ET

On August 10, 2022, Stefan Vitorovic, a member of the board of directors (the “Board”) of Praxis Precision Medicines, Inc. (the “Company”), notified the Board of his intention to resign from the Board, effective August 12, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Stefan Vitorovic resigned as Director at Praxis Precision Medicines, Inc..

Action: resigned
Role: Director

Exact text from the filing

On August 10, 2022, Stefan Vitorovic, a member of the board of directors (the “Board”) of Praxis Precision Medicines, Inc. (the “Company”), notified the Board of his intention to resign from the Board, effective August 12, 2022.

View on SEC.gov

Praxis Precision Medicines, Inc. filing history →

Source: SEC EDGAR

accession 0001689548-22-000113

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.